Drug
Sugammadex Sodium
Sugammadex Sodium is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_3
1
20%
Ph phase_4
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
NCT03679611
unknownphase_4
Postoperative Sugammadex After COVID-19
NCT05817019
completedphase_4
Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
NCT05468671
completedphase_3
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
NCT03196791
completednot_applicable
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
NCT03137290
Clinical Trials (5)
Showing 5 of 5 trials
NCT03679611Phase 4
Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
NCT05817019Phase 4
Postoperative Sugammadex After COVID-19
NCT05468671Phase 4
Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
NCT03196791Phase 3
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
NCT03137290Not Applicable
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5